STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vascular Solutions, Inc. (Nasdaq: VASC) (“Vascular Solutions” or the “Company”) relating to the proposed buyout of Vascular Solutions by Teleflex Incorporated. Under the terms of the agreement, Vascular Solutions shareholders are anticipated to receive $56.00 in cash for each share...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc. (“Vascular Solutions”) (NASDAQ:VASC) stock prior to December 2, 2016. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Vascular Solutions to Teleflex Incorporated (NYSE: TFX) for $56 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/vascular-so...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vascular Solutions, Inc. (Nasdaq: VASC) (“Vascular Solutions” or the “Company”) relating to the proposed buyout of Vascular Solutions by Teleflex Incorporated. Under the terms of the agreement, Vascular Solutions shareholders are anticipated to receive $56.00 in cash for each share...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc. (“Vascular Solutions”) (NASDAQ:VASC) stock prior to December 2, 2016. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Vascular Solutions to Teleflex Incorporated (NYSE: TFX) for $56 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/vascular-so...
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Vascular Solutions, Inc. (“Vascular”) (NASDAQ: VASC) concerning the sale to Teleflex Incorporated. Under the terms of the agreement, Vascular shareholders will only receive $56.00 for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value o...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Vascular Solutions, Inc. (NASDAQ GS: VASC)? Did you purchase any of your shares prior to December 2, 2016? Do you think the proposed buyout price is too low? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Vascular Solutions, Inc. (“Vascular Solutions” or the “Company”)...
A director at Vascular Solutions Inc sold 10,011 shares at 46.260USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.